Latest News of EXEL
Exelixis Shows Rising Price Performance With Jump To 93 RS Rating
By Investor's Business Daily |
5 days ago
Investor's Business Daily's exclusive rating, the Magnificent Seven Stocks, tracks market leadership with a score of 1 to 99. Stocks with an RS Rating of 80 or higher tend to be top market performers....
Exelon 3Q Net, Revenue Rise Amid Extreme Weather
By MarketWatch |
6 days ago
Exelon exceeded analysts' expectations in the third quarter due to increased electricity usage from hotter weather. The company reported a net income of $707 million and revenue of $6.15 billion, driv...
Exelixis Inc (EXEL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
By Yahoo! Finance |
6 days ago
Exelixis focuses on active molecules generating differentiating clinical data in the GU/GI space, agnostic to modality and deal size. The company leads in synthetic lethality assets with XL-309 and XL...
-
Exelixis (EXEL) Q3 2024 Earnings Call Transcript
By Yahoo! Finance | 6 days agoExelixis reported strong financial performance in Q3 2024 with significant momentum in the cabo franchise. Zanza collaboration with Merck is expected to drive revenue growth. The company is focused on...
-
Trump making stops in Drexel Hill and Allentown, Pennsylvania with one week to Election Day
By CBS News | 1 week agoFormer President Donald Trump is set to visit Pennsylvania for a roundtable discussion and a rally. Schools in Delaware County will dismiss early due to expected traffic. Allentown schools are closed ...
-
Exelixis Shows Market Leadership With Jump To 88 RS Rating
By Investor's Business Daily | 2 weeks agoInvestor's Business Daily tracks stock performance with RS rating from 1 to 99. Stocks with RS rating above 80 tend to perform well. Exelixis stock has good growth and is out of buy zone. Look for new...
-
Exelixis, Inc. (EXEL) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 2 weeks agoExelixis and Merck have partnered to study the combination of zanzalintinib with KEYTRUDA in head and neck cancer, and with WELIREG in renal cell carcinoma. This collaboration aims to evaluate the eff...
-
Is Exelon (EXC) The Most Profitable Utility Stock To Invest In?
By Yahoo! Finance | 3 weeks agoThe global utility market is set to grow due to factors like renewable energy investments. Exelon (NASDAQ:EXC) is a prominent energy provider with strong financials and growth potential, ranking 5th a...
-
Is Exelon (EXC) the Right Utility Investment? Analysts See 6.42% Upside Potential
By Yahoo! Finance | 3 weeks agoExelon (NASDAQ:EXC) is a top energy provider with diverse holdings in nuclear, solar, wind, and natural gas. With strong financials and a growing dividend yield, it's a solid choice for income investo...
-
Exelon Earns RS Rating Upgrade
By Investor's Business Daily | 1 month agoLearn how to manage your stock market exposure by making incremental portfolio decisions based on IBD's proprietary rating system. Find out why an RS Rating of 80 or higher is crucial for top-performi...
-
Exelon Corporation (EXC): A Good Addition To Your Infrastructure Stock Portfolio
By Yahoo! Finance | 1 month agoA list of top infrastructure stocks includes Exelon Corporation (NASDAQ:EXC), a major electricity and natural gas distributor in the US. Despite some challenges, Exelon holds promise as an investment ...
-
Jim Cramer Backs Exelon Corporation (EXC): Safe and Stable with Promising Long-Term Prospects
By Yahoo! Finance | 1 month agoJim Cramer analyzed Exelon Corporation against other stocks in his list, critiquing market analysts' explanations for stock movements. He praised Exelon's financial performance and growth prospects, r...
-
An Intrinsic Calculation For Exelon Corporation (NASDAQ:EXC) Suggests It's 20% Undervalued
By Yahoo! Finance | 1 month agoThe $41.04 analyst price target for Exelon (EXC) is 19% lower than its estimated fair value. By using the Discounted Cash Flow (DCF) model, the intrinsic value of the stock is calculated, revealing it...
-
Exelixis, Inc. (EXEL): Among Hedge Funds' Top Biotech Stock Picks
By Yahoo! Finance | 1 month agoThe article discusses the risks and complexities of investing in biotechnology stocks, focusing on Exelixis, Inc. (NASDAQ:EXEL) as a commercial stage biotech firm with a profitable track record....
-
South Carolina girlfriend of Brittanee Drexel's spring break killer stuns with key admission a decade later
By Fox News | 1 month agoAngel Vause, girlfriend of convicted Brittanee Drexel murderer Raymond Moody, pleaded guilty to lying to the FBI about Drexel's abduction. Vause faces up to five years in prison for each of her three ...